Bios
Bios develops neural interfaces and an AI platform designed to read and write the body’s neural data in real-time. The company provides infrastructure for discovering neural biomarkers and developing neural digital therapies, specifically targeting chronic conditions like cardiovascular disease. Their technology is used by pharmaceutical partners to personalize neural therapies and accelerate clinical feedback on drug efficacy.
Healthtech
Artificial Intelligence
Biotechnology
Neurotechnology
Funding summary
- Total raised
- €3.9M
- Funding rounds
- 1
Investors in Bios
Investors on record for Bios. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Bios?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors